Xtx Topco LTD Biogen Inc. Transaction History

Xtx Topco LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $855,712 - $1.08 Million	4,036 Added 128.54%	7,176 $1.55 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $227,264 - $273,566	1,021 Added 48.18%	3,140 $812,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $67,124 - $75,760	-265 Reduced 11.12%	2,119 $544,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $656,196 - $758,255	2,384 New	2,384 $679,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $137,074 - $166,548	-543 Reduced 39.55%	830 $229,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $222,725 - $307,118	-1,144 Reduced 45.45%	1,373 $367,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $96,020 - $114,186	512 Added 25.54%	2,517 $513,000
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $222,447 - $280,272	1,148 Added 133.96%	2,005 $422,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $367,900 - $472,806	-1,643 Reduced 65.72%	857 $206,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $707,475 - $922,625	2,500 New	2,500 $707,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.